CUH

Latest news

 

Norovirus - Visiting restrictions

Please help us to protect our patients.

- Visiting times on all adult wards are currently restricted to 15.00 - 17.00 and 19.00 - 20.00.

- Two adult visitors per patient only.

- Children should not visit the hospital.


TV presenter and broadcaster, Gabby Logan opens Cambridge IVF

Gabby Logan, TV presenter and broadcaster made the official opening of Cambridge IVF a very special occasion for staff on Monday 14 May.


Dying Matters awareness week 14-21 May

Dying Matters is a 16,000-member coalition set up by the National Council of Palliative Care to support changing knowledge, attitudes and behaviour towards death, dying and bereavement. It aims to make living and dying well the norm.


Young diabetics needed to take part in region-wide Games

Young people with diabetes are being encouraged to take part in the first-ever Paediatric Diabetes East of England Games to be held on 29 August 2012 in Cambridge.


Additional wheelchairs for visitors have arrived!

New wheelchairs for use by visitors are now in place. ACT has awarded a grant of £40,000 to buy 66 coin-operated wheelchairs for the hospitals. These wheelchairs are said to be 'simple to use, easy to find, hard to steal and built to last'

 

> News index

 

 

 

 

New research to reverse the damage caused by glaucoma

11 March 2011

A Cambridge University Hospitals surgeon is spearheading new research which explores the possibility of using stem cells to reverse the damage caused by glaucoma.

 

The work, led by eye surgeon Professor Keith Martin, is looking at therapies which prevent the death of nerve cells in the retina. It is hoped the study will lead to new treatments which will protect the optic nerve from damage caused by glaucoma and potentially restore sight.

 

During the research, scientists have been isolating cells from the bone marrow or blood before using them to protect the nerve cells in the retina. They are also investigating whether stem cells from the eye itself can be manipulated to heal any damage and prevent sight loss.

Prof Martin, who is also a neuroscientist at Cambridge University, described the result of early tests on animals as “very encouraging”. He now hopes to develop the treatments further so that human clinical trials can take place in future years.

 

“Glaucoma remains a leading cause of blindness worldwide and there is currently no way to restore vision once it has been lost,” said Prof Martin. “This charity funding is helping us explore the possibility that stem cell treatments could one day be used to treat glaucoma.


“Initially, we are looking at how stem cells can protect the eye against glaucoma damage when other treatment has failed. We have recently had some very encouraging results in animals with glaucoma which shows that stem cells can protect against glaucoma damage.


“In the future, our dream is to be able to use stem cell treatments to improve vision in patients with severe glaucoma. However it will be a few more years until these treatments are ready for human clinical trials”
The research has been part-funded by a £320,000 grant from Fight for Sight. The charity is also funding further research, led by Prof Martin and Dr Barbara Lorber, which looks at ways of regenerating the optic nerve by transplanting specialised retinal cells into the back of the eye.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Back to top

 

 

Contact the PR and Communications team:

 

Cambridge University Hospitals NHS Foundation Trust,

Box 53, Hills Road,

Cambridge CB2 0QQ

 

Tel: 01223 245 151

 

press@addenbrookes.nhs.uk

 

> For the press

 

> PR and Communications